Future nanomedical devices and systems will have strong potential to enable a broad range of aerospace and space applications. With further dimensional reductions in conjunction with the increased capabilities of nanoelectronics and artificial intelligence (AI), nanomedicine may facilitate the development of a wide array of advanced nanomedical diagnostic and therapeutic capabilities dedicated to the health and well being of future astronauts and space pioneers, the inhabitants of future Lunar and Mars colonies, and deep space explorers. These nanomedical innovations may form the core elements of advanced extravehicular space suits that have numerous advantages, such as continuous real-time health monitoring, virtually instantaneous in situ diagnostics, the auto-administration of therapeutics, and the capacities to address serious accidental circumstances and performance of emergency interventions.
When liquid meets gas, a unique zone forms. Variable by nature, molecules can cross from one state to another, combining in unique ways to either desirable or unwanted ends. [...]
A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta. According to a briefing from the UK Health [...]
A team of researchers has developed a new nanomechanical technique for fast, one-step, immune-affinity tests, which can quantify the immune response induced by different COVID-19 variants in serum. Their [...]
Lawrence Livermore National Laboratory (LLNL) scientists have developed a new method for 3D printing living microbes in controlled patterns, expanding the potential for using engineered bacteria to recover rare-earth [...]
Nanomedicines may offer clinicians a way to deliver precise, targeted therapy directly to tumors without damaging surrounding tissue. Yet, progress in the development of new drugs that treat cancer [...]
Cambridge researchers have discovered how T cells—an important component of our immune system—are able keep on killing as they hunt down and kill cancer cells, repeatedly reloading [...]
Sunday, October 3, set records for the most COVID-19 deaths in Russia on a single day. Only 29% of people in Russia are vaccinated, despite the country being the [...]
New research from the University of Technology Sydney (UTS) has found that pathogens that form biofilms can evolve to survive nanosilver treatment. The study is the first to demonstrate [...]
New variants of SARS-CoV-2 are more virulent and transmissible than the original variant of the virus. Health experts associate these variants of concern (VOCs) with increased risk of hospitalization, [...]
Freeze-dried genetic circuits could reveal the presence of SARS-CoV-2, Ebola, MRSA, and more. Masks and testing have been key to the COVID-19 pandemic response—and now devices that combine the [...]
Hundreds of neuroscientists built a ‘parts list’ of the motor cortex, laying groundwork to map the whole brain and better understand brain diseases. Before you read any further, bring [...]
About NanoApps Medical Inc
NanoApps Medical, Inc. was incorporated by Frank Boehm in 2009 with the goal of developing advanced nanomedical diagnostic and therapeutic technologies for the benefit of individuals across both the developing and developed worlds.
The larger picture will be to eventually attain a situation of “Global Health Care Equivalency” (GHCE) where any individual on the planet may have access to the same advanced, high quality, and cost effective nanomedical diagnostic and therapeutic technologies, no matter where they happen to reside, or under what conditions they live. Boehm is now compiling a book that will articulate this grand vision.
Further, NanoApps Medical is ambitiously aiming to transition terrestrial nanomedicine to space applications to facilitate future Lunar and Mars missions, such as those being boldly planned by NASA and SpaceX.